Deep-Tech Startups Support Program
Program overview
-
Overall picture of startups support programs in the deep-tech field
"Deep-Tech Startups Support Program" provides support for research and development and commercialization in three phases for "deep-tech startups" engaged in research and development of innovative technologies. Eligible projects are those that require long-term research and development and large-scale funding to establish the technology, commercialize it, and implement it in society and that are considered to contribute to solving economic and social issues (carbon neutrality, resource circulation, economic security, etc.) to be addressed by the country or the world as a whole, despite the high risk involved.
Deep-Tech Startups Support Program (DTSU): Aims and Measures
-
Deep-Tech Startups Support Program: Aims and Measures
Details of Support
Program Flow, Program Period, NEDO's Contribution Rate, and Maximum subsidy Amount
-
Phases to be supported
Phase | Maximum program period*(1) | NEDO's contribution rate | Maximum subsidy amount | ||
---|---|---|---|---|---|
(1) STS | Up to four years for each phase. | [Once-through support] Six years (One program period is the period until the next round of fundraising.) |
Within 2/3 of the subsidy-eligible expenses | 300 million yen or 500 million yen *(2) | Total Up to 3 billion yen |
(2) PCA | 500 million yen or 1 billion yen *(2) | ||||
(3) DMP | Within 2/3 of the subsidy-eligible expenses or 1/2 of the subsidy-eligible expenses *(3) | 2.5 billion yen |
- *(1): The program period is set based on the period from the time when the business receives investment from VCs, CVCs, or other operating companies when it applies for this support program until the next time when the business plans receives investment from VCs, CVCs, or other operating companies (new fundraising). Approximately 1.5 to two years are standard. The maximum period in the above table can be set by going through the Stage-Gate (SG) reviewing process.
- *(2): Conditions for subsidy increase: When the partner in the commercialization partnership is able to submit a statement of intent and a plan for overseas technology demonstrations
- *(3): Conditions for 1/2 contribution rate: When the ratio of the total amount of loans to the total amount of investments and loans in the DMP phase is 1/2 or more.
Each project can be continued in the same phase or the next phase if it is approved by the Stage-Gate review.
Timing of Application and Stage-Gate Scheme
Applications can be submitted from any phases. However, each proposer may apply for only one phase that best fits one’s company.
(To apply for a phase, the applicant is required to judge the suitability of the phase based on the most advanced business or research and development activities in one’s company).
Public recruitment will be open for five years, from FY2023 to FY2027.
-
Timing of Application and Stage-Gate Scheme
The support for each phase of the program is as follows.
Phase | STS phase | PCA phase | DMP phase |
---|---|---|---|
Target |
|
|
|
Support |
|
|
|
Subsidy rate | 2/3 or less | 2/3 or less | 2/3 or less or 1/2 or less *(3) |
Subsidy amount | 300 million yen or 500 million yen *(1) | 500 million yen or 1 billion yen *(1) | 2.5 billion yen |
Major requirements (for details, refer to the open call guidelines) |
|
|
|
- *(1): The maximum amount can be increased when the partner in the commercialization partnership is able to submit a letter of intent and a plan for overseas technological demonstrations.
- *(2): Investments include convertible securities (convertible equity, convertible bonds, convertible notes, etc.)
- *(3): If the ratio of the total loan amount to the total investment and loan amount required to apply for the program is 1/2 or more, the subsidy rate will be reduced to 1/2 or less.
- *(4): A period separately determined by NEDO based on the period from three months before the proposal deadline to one month after the date of the decision to adopt.
Adopted projects
Company Name | Research theme | Fiscal year of adoption | Phase | |
---|---|---|---|---|
A | AgroDesign Studios | Accelerate creation of novel agrochemicals using molecularly targeted agrochemical platforms | 2023 | STS |
AMI Inc. | Social Implementation of the Heart Sound AI Diagnostic Assistance System and Development of Heart Sound Biomarkers | 2023 | PCA | |
Anaut inc. | Integration of surgical support AI technology with next-generation medical devices and global expansion | 2023 | PCA | |
ARCS Inc. | Development of automation systems for assisted reproductive technologies | 2023 | STS | |
A-SEEDS Co., Ltd. | Development of Mass-Production Technology for the Clinical Implementation of Innovative CAR-T Cell Therapy | 2023 | PCA | |
ASTER Co., Ltd. | Demonstration of mass production for social implementation of the ASTERMOTOR drive system | 2023 | DMP | |
B | BiPSEE Inc. | Development of VR digital therapy for depression | 2023 | STS |
bitBiome, Inc. | Technological Enhancements and Business Validation Toward International Development of Microbial Gene Database | 2023 | PCA | |
Boston Medical Sciences, Inc. | Development of a non-invasive colorectal cancer screening system based on deep learning | 2023 | STS | |
C | CaTe Inc. | Development of exercise workload optimization function and cardiac rehabilitation program medical device | 2023 | STS |
CellFiber Co., Ltd. | GMP manufacturing of cells with CellFiberTM Technology | 2023 | PCA | |
Cosomil, Inc. | Globalization of Single Enzyme Activity-based Liquid Biopsy | 2023 | STS | |
E | ElevationSpace Inc. | Development of High-Frequency Space Experimentation and Recovery Platform. | 2023 | STS |
EX-Fusion Inc. | Realization of high-precision, high-speed machining of difficult-to-process materials by high-power laser processing machines | 2023 | STS | |
F | Fermelanta, Inc. | Microbial production of useful compounds by multistep gene introduction system | 2023 | STS |
FLOSFIA INC. | Demonstration of low-cost mass production of high-performance α-Ga2O3 power semiconductors | 2023 | DMP | |
FuturedMe Inc. | Construction of drug development platform of disease-specific degradation by CANDDY | 2023 | STS | |
G | Galdieria, Co., Ltd. | Launching a resource recycling business applying microalgae to precious metal recycling adsorbents. | 2023 | PCA |
GramEye Inc. | Commercialization development of Gram staining automated AI medical device and overseas demonstration project | 2023 | PCA | |
I | Integral Geometry Science, Inc. | Research for mass-production of in-line battery inspection equipment of current density distribution | 2023 | DMP |
K | KAICO Ltd. | Research and development of base manufacturing towards commercialization of oral vaccine/feed additives for swine | 2023 | PCA |
L | Letara Ltd. | Development of a small hybrid thruster for a small spacecraft | 2023 | STS |
LexxPluss, Inc. | Development of autonomous heavy transport robots for mixed-flow production in a human coexistence environment. | 2023 | DMP | |
LinqMed Inc. | Development of the drug discovery platform based on 64Cu to expedite the R&D of new-generation drugs | 2023 | PCA | |
LQUOM, Inc. | Development of long-distance quantum communication system and market creation | 2023 | STS | |
Luxonus Inc. | Development of flexible-arm photoacoustic imaging system | 2023 | PCA | |
M | MaRI Co., Ltd. | Innovative medical device based on contactless bioinformation measurement using mmwave radar | 2023 | PCA |
Metroweather Co.,Ltd. | Development of small, low-cost Doppler LiDARs and accuracy verification methods for mass production. | 2023 | PCA | |
MiCAN Technologies, Inc. | Development of MylcMAT products using immortalized monocytic cells aMylc | 2023 | PCA | |
MJOLNIR SPACEWORKS Inc. | Development of mass-produced hybrid rocket system | 2023 | STS | |
Morus Inc. | Creation of a Japanese materials industry through mass production and overseas expansion of silkworm biomaterials | 2023 | STS | |
N | N.B.Medical Inc. | Development of an Innovative Anti-Thrombotic Coated Stent for Intracranial Aneurysm Treatment | 2023 | STS |
Nanofiber Quantum Technologies, Inc. | Development of quantum repeater utilizing cavity QED | 2023 | STS | |
Nature Architects, Inc. | Development of innovative EV component design environment utilizing metamaterials | 2023 | PCA | |
P | Pale Blue Inc | Establishment of mass production technology for a propulsion system using water as a propellant for artificial satellites. | 2023 | DMP |
R | Rapyuta Robotics Company Limited | Development to expand the introduction of picking and storage solutions into warehouses | 2023 | DMP |
RICOS Co. Ltd. | AI-based Thermal-Fluid Simulation Leading to Automated Product Design | 2023 | STS | |
S | Sonire Therapeutics Inc. | Research and development for practical application of next-generation focused ultrasound therapy system for refractory cancer | 2023 | PCA |
T | T.G.Medical Inc. | Commercialization of a device for the treatment of acute ischemic stroke due to atherosclerosis. | 2023 | STS |
TeraWatt Technology K.K. | Mass production verification of ultra-high energy and ultra-high power density lithium-ion batteries | 2023 | DMP | |
ThinkCyte K.K. | Demonstration of mass production of an AI-based high-throughput cell analysis and sorting system | 2023 | DMP | |
TIER IV, Inc. | Development of software-embedded electrification modules for autonomous driving | 2023 | DMP | |
TKG Therapeutics, Inc. | R&D of a new immersive solid-phase synthesis method | 2023 | STS | |
U | United Immunity Co., Ltd. | Development of drug delivery capsule that selectively delivers mRNA et al. to immune cells | 2023 | STS |
W | WOTA CORP. | Development of a mass production-ready "Small-scale, decentralised water recycling system for residential use" | 2023 | DMP |
# | 3D Architech, Inc. | Development of micro-architected gas diffusion layer for electrolysis with high output and low cost | 2023 | STS |
Basic information
Technical field | Cross-sectoral proposal-based programs |
---|---|
Project code | P23019 |
Department in charge | Innovation Promotion Department (E-MAIL: dtsu@nedo.go.jp ) |
Last Updated : May 10, 2024